Irfan serves as the Managing Director of DSSL. He is a trained physician and holds a Master’s Degree in Molecular Medicine from University College London. He has over 18 years’ experience in the pharmaceutical industry, having worked in leadership roles for both large and medium-size biopharmaceutical companies, in clinical development and pharmacovigilance. This experience has resulted in his extensive knowledge and insightful understanding of the global pharmacovigilance and clinical development landscape.
He has hands-on expertise in formulating and applying best practices in pharmacovigilance across Europe/US/Japan and has been instrumental in driving a pro-active approach to patient safety and risk management globally.
Rob is an industry veteran; his experience includes leading pharmacovigilance operations groups for top 10 pharma and have provided consulting services to Regulatory Authorities. He is passionate about delivering patient safety through process design and technology and he has gained significant experience in traditional pharma products as well as the development of new wave products such as gene and cell therapies.
Maikel is a qualified nurse with over 14 years of experience in the pharmaceutical industry. Highly experienced in pharmacovigilance, case processing, and aggregate report writing, he has specialized in working for both marketed and under development product lines. In addition to his extensive in PV operations, he is a qualified auditor who has led global PV auditing programs. Having taken part and played critical roles in pharmacovigilance related projects. PV inspections, and audits, Maikel Hofwijks also serves as EU QPPV for several DSSL clients.
Rahul is a physician, who for more than 12 years has worked in Pharmacovigilance and clinical research. Rahul’s expertise includes safety review strategies, signal management, aggregate report writing, Risk Management Planning and Minimization activities, case processing and literature surveillance.